162 related articles for article (PubMed ID: 36927233)
1. PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.
Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J
Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233
[No Abstract] [Full Text] [Related]
2. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer.
Huang J; Zheng Y; Zheng X; Qian B; Yin Q; Lu J; Lei H
Cell Transplant; 2021; 30():9636897211001772. PubMed ID: 33829865
[TBL] [Abstract][Full Text] [Related]
4. PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer.
Zheng Y; Ji H; Yi W; Chen Z; Hu X; Zhou J; Wang Y; Zheng X
Aging (Albany NY); 2023 Jul; 15(13):6163-6178. PubMed ID: 37400960
[TBL] [Abstract][Full Text] [Related]
5. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
[TBL] [Abstract][Full Text] [Related]
6. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
Zhang S; Ma Y; Hu X; Zheng Y; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
[TBL] [Abstract][Full Text] [Related]
7. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
8. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
[TBL] [Abstract][Full Text] [Related]
9. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
10. PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by Resveratrol.
Li Y; Yang Y; Liu X; Long Y; Zheng Y
Cell Transplant; 2019 Dec; 28(12):1664-1673. PubMed ID: 31665911
[TBL] [Abstract][Full Text] [Related]
11. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
Chung J; Karkhanis V; Baiocchi RA; Sif S
J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
[TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.
Gu Z; Gao S; Zhang F; Wang Z; Ma W; Davis RE; Wang Z
Biochem J; 2012 Sep; 446(2):235-41. PubMed ID: 22708516
[TBL] [Abstract][Full Text] [Related]
14. Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma.
Yang D; Liang T; Gu Y; Zhao Y; Shi Y; Zuo X; Cao Q; Yang Y; Kan Q
Oncol Rep; 2016 Mar; 35(3):1703-10. PubMed ID: 26708443
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
[TBL] [Abstract][Full Text] [Related]
16. miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.
Jing P; Zhao N; Xie N; Ye M; Zhang Y; Zhang Z; Li M; Lai X; Zhang J; Gu Z
J Immunol Res; 2018; 2018():2834109. PubMed ID: 29850625
[TBL] [Abstract][Full Text] [Related]
17. PRMT5 activates AKT via methylation to promote tumor metastasis.
Huang L; Zhang XO; Rozen EJ; Sun X; Sallis B; Verdejo-Torres O; Wigglesworth K; Moon D; Huang T; Cavaretta JP; Wang G; Zhang L; Shohet JM; Lee MM; Wu Q
Nat Commun; 2022 Jul; 13(1):3955. PubMed ID: 35803962
[TBL] [Abstract][Full Text] [Related]
18. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract][Full Text] [Related]
20. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells.
Zhu F; Guo H; Bates PD; Zhang S; Zhang H; Nomie KJ; Li Y; Lu L; Seibold KR; Wang F; Rumball I; Cameron H; Hoang NM; Yang DT; Xu W; Zhang L; Wang M; Capitini CM; Rui L
Leukemia; 2019 Dec; 33(12):2898-2911. PubMed ID: 31123343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
